Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

China

 

Interview: Jeremy Low, board member Weihai Thonburi – “In China, there are no easy shortcuts, but it’s worth it”

How do foreign operators crack the notoriously tricky Chinese market? Is it possible for non-natives to come in, win over the local population, cut through swathes of red tape and make a profit? We speak to Jeremy Low, director of Weihai Thonburi Healthcare Investment Company, a subsidiary of Bangkok-based Thonburi Hospital Group, which is about to open a 250 bed hospital.
October 13, 2016

Wound care clinics – the potential in emerging markets

The potential for wound care clinics – especially in emerging markets – is huge. Often costing little to set up, the opportunity to cut costs, cut average length of stay, and operate a quick turnaround (ideally from private payors) should be appealing. So why aren’t we seeing more of them? Healthcare Nova speaks to Rafael Mazuz, MD of OliveSeraph which advises providers how to make such clinics work.
September 22, 2016

Ramsay shares rise on profit hike

Shares in big private hospital group Ramsay Health Care rose nearly 8% to AUD81.4. The operator which is top dog inFrance and one of the top three in the UK saw net profit after tax rise 16.8% to AUD 482m (€325 m) with group revenue ahead 18.1% to AUD 8.7bn (5.88bn) in the year to June 2016. We analyse the results.
August 30, 2016

China Resources to buy GenesisCare

Macquarie-backed, state-owned conglomerate China Resources (CR) is waiting for Australian regulatory approval to buy private equity house KKR's 45% stake in oncology group GenesisCare. CR wants to continue expanding Genesis in Western Europe and to tap the Chinese market with new hospital management contracts. The deal values the company at US$1.3bn.
July 26, 2016

Raffles plans US$735m expansion

Singapore hospital operator Raffles Medical Group is to spend US$735m (S$1bn) in the next three years to expand its presence across Asia, especially in China.
July 20, 2016

Carlyle to exit Concord

Private equity house Carlyle is exiting Chinese outsourcing group Concord Medical Services as management delists the company from the New York Stock Exchange. CEO Jianyu Yang's investment vehicle Morgancreek Investment and partner Blue Ocean Management will gain full ownership. They plan to expand the business to wholly owned cancer centres.
July 20, 2016

Diaverum enters China

Renal care provider Diaverum is entering China through a JV with state-owned conglomerate Yueda. The group is planning to build a network, initially in a handful of provinces including Jiangsu and Guangdong citing huge demand and decent public reimbursement schemes. We speak to Mans Olsson, Head of Middle East and Asia.
July 19, 2016
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us